Related to Novo Nordisk and Merrion Sign €1.5M Deal for Oral Formulation Technology

• Feature Articles: Refining Protein Drug Formulation
  
• Feature Articles: Strategies for Successful Formulation
  
• Corporate Profiles: Merrion Strives to Turn IV Drugs into Tablets
  
• Tutorials: Analytical Considerations in Formulation
  
• Feature Articles: Protein Therapeutic Formulation Issues
  
• Feature Articles: Timing Is Everything in Protein Formulation
  
• Feature Articles: Reformulations Must Provide Added Value
  
• Tutorials: Optimizing Biologics Formulations
  
• Corporate Profiles: Tackling the Problems of Insolubility
  
• Tutorials: Expediting Early Preformulation Studies
  
• Feature Articles: Devising a Protein Formulation Strategy
  
• Wall Street BioBeat: Vaccine Advances Drive Differentiation